Ansell (ASX:ANN): FY26 Protective Equipment Earnings and FY27 Guidance

Aditi Sarkar

12 November 2026 04:39 PM AEDT

Ansell (ASX:ANN): FY26 Protective Equipment Earnings and FY27 Guidance

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Ansell (ASX:ANN) reported FY26 sales of USD 2,140.2 million.
Adjusted EBIT reached USD 321.9 million, up 14.1%.
FY27 adjusted EPS guidance is US 158–170 cents.
ANN shares were AUD 47.00 on 12 November 2026, up 1.08%.

Ansell Limited (ASX:ANN) manufactures personal protective equipment used in healthcare, industrial and scientific workplaces worldwide. On 12 November 2026, Ansell shares traded at AUD 47.00, a 1.08% increase during the session. Its FY26 results and FY27 outlook centre on growth in safety-product sales, improved adjusted earnings, sourcing changes and management of tariff-related costs.

Healthcare and Industrial Protection

Ansell (ASX:ANN) reports Healthcare and Industrial Business segments. Healthcare products include surgical, examination and single-use gloves and cleanroom protection, while the Industrial segment offers mechanical and chemical protection solutions. Customers include healthcare providers and workplaces requiring specialist protection from hazards. The group’s international Manufacturing and distribution activities create exposure to freight rates, raw-material inputs, regional Demand and Import tariffs. The distinction between sales to distributors and eventual end-user demand can also matter when customers adjust inventory levels.

FY26 Sales, Profit and Cash Flow

For the year ended 30 June 2026, Ansell (ASX:ANN) reported sales of USD 2,140.2 million, up 6.8% on a reported basis and 5.0% in organic constant currency. Adjusted EBIT increased 14.1% to USD 321.9 million, while adjusted EBIT Margin rose to 15.0% from 14.1%. Statutory net profit after tax increased to USD 208.6 million from USD 101.6 million. Adjusted net profit after tax was USD 212.3 million, up 15.8%. The company reported adjusted Earnings per share of US 148.6 cents, compared with US 126.1 cents.

Operating cash flow, calculated according to Ansell’s disclosed definition, increased to USD 270.1 million from USD 105.4 million. Net Debt to adjusted EBITDA was 1.3 times at June 2026. The company reported USD 118.4 million of share Buybacks during the year and declared a final unfranked dividend of US 41.5 cents per share. Adjusted measures exclude significant items and should not be treated as identical to statutory profit.

Segment Trends and Cost Responses

Ansell (ASX:ANN) reported Industrial sales of USD 947.3 million and Healthcare sales of USD 1,192.9 million in FY26. Industrial adjusted EBIT was USD 170.6 million, while Healthcare adjusted EBIT was USD 170.7 million. The company cited demand for selected mechanical, surgical and cleanroom products and supply-chain productivity as contributors. It also reported taking pricing and sourcing actions to offset higher US tariffs and cost pressures associated with disruptions in the Middle East. These actions were described in relation to FY26 performance and should not be interpreted as eliminating future Tariff or input-cost exposure.

FY27 Outlook and Business Risks

For FY27, Ansell forecast adjusted Earnings Per Share of US 158–170 cents, compared with US 148.6 cents in FY26. The outlook assumes constant-currency sales growth from higher volumes and pricing actions, along with productivity initiatives. It also includes expected Capital Expenditure of USD 45–55 million and net interest costs of about USD 43 million. These forecasts are management guidance rather than results. Trade policy changes, sourcing disruptions, input costs, currency exposure and demand from healthcare and industrial customers remain relevant variables. Ansell (ASX:ANN) also plans enterprise-resource-planning upgrades, which introduce implementation costs and execution considerations.

What to Watch Next

Following its 9 November 2026 annual general meeting, subsequent communications may provide updates on trading against FY27 expectations and tariff costs. Investors can monitor Volume growth separately from pricing effects, particularly where advance customer orders distort period comparisons. The company has also indicated continuation of its existing USD 200 million share buyback program in FY27, subject to its implementation. Cash Flow and net Leverage will help contextualise distributions and Investment spending.

Key Insights

Ansell’s FY26 figures showed increases in reported sales, adjusted earnings and operating cash flow. The group’s Healthcare and Industrial products serve different end markets, while FY27 management guidance assumes further commercial and operational progress. Tariffs, costs and implementation milestones remain points for future monitoring.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.